Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

101. Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D for children and young people with neuromuscular disorders in the UK

Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D for children and young people with neuromuscular disorders in the UK Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D for children and young people with neuromuscular disorders in the UK | Great Ormond Street Hospital Google Tag Manager Navigation Search Search You are here Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D (...) for children and young people with neuromuscular disorders in the UK Neuromuscular disorders: prophylaxis and treatment guidelines for calcium and vitamin D for children and young people with neuromuscular disorders in the UK ). Children with reduced exposure to sunlight (such as those who have poor mobility, those with clothing that limits exposure ( ). Children (particularly those with Duchenne Muscular Dystrophy) who are at increased risk of fracture as a result of long term steroid use ( ). Children

2014 Publication 1593

102. Systematic review: Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour Full Text available with Trip Pro

Systematic review: Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Calcium channel blockers are effective as first line for tocolysis in the management of preterm labour Article Text Therapeutics Systematic review Calcium channel

2014 Evidence-Based Medicine

103. Cohort study: Calcium supplements associated with increased risk of cardiovascular death in men but not women

Cohort study: Calcium supplements associated with increased risk of cardiovascular death in men but not women Calcium supplements associated with increased risk of cardiovascular death in men but not women | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Calcium supplements associated with increased risk of cardiovascular death in men but not women Article Text Primary health care Cohort study Calcium supplements associated with increased

2014 Evidence-Based Nursing

104. Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness

Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness CADTH Record Status This is a bibliographic record of a published (...) health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2014 Authors' conclusions There remains a paucity of good quality evidence to support the use of docusate

2014 Health Technology Assessment (HTA) Database.

105. Cohort study: Daily calcium intake in excess of 1400?mg is associated with increased all-cause and cardiovascular disease mortality in women

Cohort study: Daily calcium intake in excess of 1400?mg is associated with increased all-cause and cardiovascular disease mortality in women Daily calcium intake in excess of 1400 mg is associated with increased all-cause and cardiovascular disease mortality in women | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see (...) our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Daily calcium intake in excess of 1400 mg is associated with increased all-cause and cardiovascular disease mortality

2014 Evidence-Based Nursing

106. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. Full Text available with Trip Pro

Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. Calcium-channel blockers are metabolized by the cytochrome P450 3A4 (CYP3A4; EC 1.14.13.97) enzyme. Blood concentrations of these drugs may rise to harmful levels when CYP3A4 activity is inhibited. Clarithromycin is an inhibitor of CYP3A4 and azithromycin is not, which makes comparisons between these 2 macrolide antibiotics useful in assessing clinically important drug interactions.To characterize the risk (...) of acute adverse events following coprescription of clarithromycin compared with azithromycin in older adults taking a calcium-channel blocker.Population-based retrospective cohort study in Ontario, Canada, from 2003 through 2012 of older adults (mean age, 76 years) who were newly coprescribed clarithromycin (n = 96,226) or azithromycin (n = 94,083) while taking a calcium-channel blocker (amlodipine, felodipine, nifedipine, diltiazem, or verapamil).Hospitalization with acute kidney injury (primary

2013 JAMA

107. Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation (Abstract)

Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation Osteoporosis and fractures are frequently encountered in patients with Crohn's disease. In order to prevent fractures, treatment with bone protecting drugs appears warranted early in the course of bone disease when bone loss is not yet prominent. We therefore aimed to demonstrate a beneficial (...) effect on bone density of the bisphosphonate risedronate in osteopenic Crohn's disease patients.This double-blind, placebo-controlled randomised trial of risedronate with calcium and vitamin D supplementation was performed in osteopenic Crohn's disease patients. Patients were treated for 2 years with follow-up after 3 and after every 6 months. Disease characteristics and activity and bone turnover markers were assessed at all visits; dual x-ray absorptiometry was performed at baseline, 12 and 24

2013 EvidenceUpdates Controlled trial quality: predicted high

108. Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events. Full Text available with Trip Pro

Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular Events. Coronary artery calcium (CAC), measured by computed tomography (CT), has strong predictive value for incident cardiovascular disease (CVD) events. The standard CAC score is the Agatston, which is weighted upward for greater calcium density. However, some data suggest increased plaque calcium density may be protective for CVD.To determine the independent associations of CAC volume and CAC density with incident

2013 JAMA

109. Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones Full Text available with Trip Pro

Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones Higher urinary uric acid excretion is a suspected risk factor for calcium oxalate stone formation. Febuxostat, a xanthine oxidoreductase inhibitor, is effective in lowering serum urate concentration and urinary uric acid excretion in healthy volunteers and people with gout. This work studied whether febuxostat, compared with allopurinol and placebo (...) , would reduce 24-hour urinary uric acid excretion and prevent stone growth or new stone formation.In this 6-month, double-blind, multicenter, randomized controlled trial, hyperuricosuric participants with a recent history of calcium stones and one or more radio-opaque calcium stone ≥ 3 mm (as seen by multidetector computed tomography) received daily febuxostat at 80 mg, allopurinol at 300 mg, or placebo. The primary end point was percent change from baseline to month 6 in 24-hour urinary uric acid

2013 EvidenceUpdates Controlled trial quality: predicted high

110. Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi

Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi BestBets: Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi Report By: Alexander Stewart - 4th Year Medical Student Search checked by Craig Ferguson - Consultant in Emergency Medicine Institution: Manchester University Date Submitted: 11th July 2012 Date Completed: 17th April 2013 Last Modified (...) : 17th April 2013 Status: Green (complete) Three Part Question In [adult patients with urinary calculi] is [treatment with alpha receptor blockers superior to treatment with calcium channel antagonists] at [increasing the speed and success of spontaneous stone passage]? Clinical Scenario A 51 year old presents to A&E with loin pain and macroscopic haematuria and a diagnosis of renal calculi is made. The patient’s pain is adequately controlled and the decision is discharge with Medical Expulsive

2013 BestBETS

111. An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone Full Text available with Trip Pro

An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone The OSCAR study was a multicenter, prospective randomized open-label blinded end-point study of 1164 Japanese elderly hypertensive patients comparing the efficacy of angiotensin II receptor blocker (ARB) uptitration to an ARB plus calcium channel blocker (CCB

2013 EvidenceUpdates Controlled trial quality: uncertain

112. Backfilling of iliac crest defects with hydroxyapatite-calcium triphosphate biphasic compound: a prospective, randomized computed tomography and patient-based analysis (Abstract)

Backfilling of iliac crest defects with hydroxyapatite-calcium triphosphate biphasic compound: a prospective, randomized computed tomography and patient-based analysis Hydroxyapatite-calcium triphosphate (HCT) biphasic compounds are known to be efficacious in filling bone voids. No large study to date has assessed their radiographic efficacy in iliac crest voids with computed tomography (CT) analysis at a 2-year follow-up.To assess whether backfilling iliac crest defects with HCT biphasic

2013 EvidenceUpdates Controlled trial quality: uncertain

113. Mineral Trioxide Aggregate Superior to Calcium Hydroxide in Pulpotomized Primary Molars

Mineral Trioxide Aggregate Superior to Calcium Hydroxide in Pulpotomized Primary Molars UTCAT2415, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Mineral Trioxide Aggregate Superior to Calcium Hydroxide in Pulpotomized Primary Molars Clinical Question In pulpotomized primary dentition, does Mineral Trioxide Aggregate produce superior results as compared to Calcium Hydroxide? Clinical Bottom Line Mineral Trioxide (...) Aggregate yielded superior results when used in primary molars in both radiographic and clinical findings. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient Group Study type (level of evidence) #1) Liu/2011 17 children Randomized Controlled Trial Key results In the treatment primary molars with MTA, the success rate was 94.1% with crown discoloration being the common complaint. In primary molars treated with Calcium Hydroxide, internal root

2013 UTHSCSA Dental School CAT Library

114. Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement. Full Text available with Trip Pro

Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement. New U.S. Preventive Services Task Force (USPSTF) recommendation statement on vitamin D and calcium supplementation to prevent fractures in adults.The USPSTF commissioned 2 systematic evidence reviews and a meta-analysis on vitamin D supplementation with or without calcium to assess the effects of supplementation on bone health outcomes in community-dwelling adults (...) , the association of vitamin D and calcium levels with bone health outcomes, and the adverse effects of supplementation.These recommendations apply to noninstitutionalized or community-dwelling asymptomatic adults without a history of fractures. This recommendation does not apply to the treatment of persons with osteoporosis or vitamin D deficiency.The USPSTF concludes that the current evidence is insufficient to assess the balance of the benefits and harms of combined vitamin D and calcium supplementation

2013 Annals of Internal Medicine

115. Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. Full Text available with Trip Pro

Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. To investigate the association between long term intake of dietary and supplemental calcium and death from all causes and cardiovascular disease.Prospective longitudinal cohort study.Swedish mammography cohort, a population based cohort established in 1987-90.61 433 women (born between 1914 and 1948) followed-up for a median of 19 years.Primary outcome measures (...) , identified from registry data, were time to death from all causes (n=11 944) and cause specific cardiovascular disease (n=3862), ischaemic heart disease (n=1932), and stroke (n=1100). Diet was assessed by food frequency questionnaires at baseline and in 1997 for 38 984 women, and intakes of calcium were estimated. Total calcium intake was the sum of dietary and supplemental calcium.The risk patterns with dietary calcium intake were non-linear, with higher rates concentrated around the highest intakes

2013 BMJ

116. Calcium and vitamin D supplementation and cognitive impairment in the women`s health initiative Full Text available with Trip Pro

Calcium and vitamin D supplementation and cognitive impairment in the women`s health initiative To examine the effects of vitamin D and calcium on cognitive outcomes in elderly women.Post hoc analysis of a randomized double-blind placebo-controlled trial.Forty Women's Health Initiative (WHI) clinical centers across the United States.Four thousand one hundred forty-three women aged 65 and older without probable dementia at baseline who participated in the WHI Calcium and Vitamin D Trial (...) and the WHI Memory Study.Two thousand thirty-four women were randomized to receive 1,000 mg of calcium carbonate combined with 400 IU of vitamin D(3) (treatment) and 2,109 to placebo.Primary: classifications of probable dementia or mild cognitive impairment (MCI) based on a four-phase protocol that included central adjudication. Secondary: global cognitive function and individual cognitive subtests.Mean age of participants was 71. During a mean follow-up of 7.8 years, 39 participants in the treatment

2013 EvidenceUpdates Controlled trial quality: predicted high

117. Cohort study: Opposite impacts of dietary versus supplemental calcium on cardiovascular health

Cohort study: Opposite impacts of dietary versus supplemental calcium on cardiovascular health Opposite impacts of dietary versus supplemental calcium on cardiovascular health | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Opposite impacts of dietary versus supplemental calcium on cardiovascular health Article Text Prognosis Cohort study Opposite impacts of dietary versus supplemental calcium on cardiovascular health Idris Guessous 1 , 2

2013 Evidence-Based Medicine

118. Population Screening Act: calcium score and the risk of cardiovascular disease

Population Screening Act: calcium score and the risk of cardiovascular disease Population Screening Act: calcium score and the risk of cardiovascular disease Population Screening Act: calcium score and the risk of cardiovascular disease Health Council of the Netherlands Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Health Council of the Netherlands. Population (...) Screening Act: calcium score and the risk of cardiovascular disease. The Hague: Health Council of the Netherlands Gezondheidsraad (GR). 2013/09. 2013 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Calciums; Cardiovascular Diseases; Predictive Value of Tests Language Published English Country of organisation Netherlands English summary An English language summary is available. Address for correspondence Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340 7520

2013 Health Technology Assessment (HTA) Database.

119. Does Calcium Administration During Cardiopulmonary Resuscitation Improve Survival for Patients in Cardiac Arrest?

Does Calcium Administration During Cardiopulmonary Resuscitation Improve Survival for Patients in Cardiac Arrest? Systematic Review Snapshot TAKE-HOME MESSAGE Irrespective of presenting rhythm, in patients with cardiac arrest there is no conclusive evidence that administration of calcium during cardiopulmonary resuscitation (CPR) improves survival. Does Calcium Administration During Cardiopulmonary Resuscitation Improve Survival for Patients in Cardiac Arrest? EBEM Commentators Adaira Landry (...) in the ILCOR submission, and the quality of each study was classi?ed as nothing better than fair. Ofthe 10, only 2 by Stueven etal 2,3 wereblindedrandomizedtrials Table. Levels of evidence and quality of 10 studies supporting, opposing, or neutral to calcium administration during CPR from cardiac arrest.* Level of Evidence 12 3 4 5 Quality of study Evidence supporting Poor Kay and Blalock 1 Evidence neutral Fair Stueven 2,3 Poor Gando 4 Harrison and Amey 5 Evidence opposing Fair Stueven 6 Urban 7 Poor

2013 Annals of Emergency Medicine Systematic Review Snapshots

120. Higher dietary intakes of potassium, calcium and magnesium are associated with a reduced risk of developing vascular dementia

Higher dietary intakes of potassium, calcium and magnesium are associated with a reduced risk of developing vascular dementia Higher dietary intakes of potassium, calcium and magnesium are associated with a reduced risk of developing vascular dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log (...) in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Higher dietary intakes of potassium, calcium and magnesium are associated with a reduced risk of developing vascular dementia Article Text

2013 Evidence-Based Mental Health